Unknown

Dataset Information

0

Design, Synthesis, and Biological Evaluation of Pyrano[2,3-c]-pyrazole-Based RalA Inhibitors Against Hepatocellular Carcinoma.


ABSTRACT: The activation of Ras small GTPases, including RalA and RalB, plays an important role in carcinogenesis, tumor progress, and metastasis. In the current study, we report the discovery of a series of 6-sulfonylamide-pyrano [2,3-c]-pyrazole derivatives as novel RalA inhibitors. ELISA-based biochemical assay results indicated that compounds 4k-4r suppressed RalA/B binding capacities to their substrates. Cellular proliferation assays indicated that these RalA inhibitors potently inhibited the proliferation of HCC cell lines, including HepG2, SMMC-7721, Hep3B, and Huh-7 cells. Among the evaluated compounds, 4p displayed good inhibitory capacities on RalA (IC50 = 0.22 μM) and HepG2 cells (IC50 = 2.28 μM). Overall, our results suggested that a novel small-molecule RalA inhibitor with a 6-sulfonylamide-pyrano [2, 3-c]-pyrazole scaffold suppressed autophagy and cell proliferation in hepatocellular carcinoma, and that it has potential for HCC-targeted therapy.

SUBMITTER: Wang Y 

PROVIDER: S-EPMC8634879 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC10892497 | biostudies-literature
| S-EPMC8622706 | biostudies-literature
| S-EPMC10537540 | biostudies-literature
| S-EPMC10536156 | biostudies-literature
| S-EPMC8694318 | biostudies-literature
| S-EPMC3099764 | biostudies-literature
| S-EPMC9090729 | biostudies-literature
| S-EPMC8073777 | biostudies-literature
| S-EPMC9933482 | biostudies-literature
| S-EPMC8954831 | biostudies-literature